The FDA Circular No. 2025-003 issued by the Philippine Food and Drug Administration (FDA) marks a significant regulatory advancement by formally adopting the Codex Guidelines for Ready-to-Use Therapeutic Foods (RUTF) CXG 95-2022 Rev. 2023 as a technical regulation. This move aligns national food safety standards with international benchmarks, ensuring the quality, safety, and efficacy of RUTF products distributed locally, particularly for children aged 6 to 59 months suffering from Severe Acute Malnutrition (SAM).

Key Highlights:
1. Background and Legal Basis: The circular is rooted in the constitutional mandate to protect public health and is supported by laws such as Republic Act No. 3720, RA No. 10611 (Food Safety Act of 2013), and Executive Order No. 51 (Milk Code). These laws empower the FDA to regulate food products and harmonize local standards with international norms 1.

2. Definition and Scope: RUTF is defined as a high-energy, nutrient-dense food for special medical purposes, designed for children with SAM who do not have medical complications. These foods are soft, crushable, and require no preparation. The circular explicitly excludes other products like Ready-to-Use Supplementary Foods (RUSF), micronutrient supplements, and canned baby foods 1.

3. Regulatory Requirements: All Food Business Operators (FBOs) must obtain a License to Operate (LTO) and a Certificate of Product Registration (CPR) before engaging in any activity related to RUTF. These processes must comply with Administrative Order No. 2014-0029 and FDA Circular 2020-033 1.

4. Technical Standards: The Codex Guidelines set stringent parameters for:

Raw materials: Only safe, approved ingredients like legumes, seeds, and oils may be used. Harmful items like field beans and honey are prohibited due to health risks.
Nutritional composition: RUTF must contain 10–12% energy from protein (at least 50% from milk), 45–60% from lipids, and essential vitamins and minerals as per AnnexA.
Food additives and contaminants: Only specific additives are allowed, and contaminants must be strictly controlled.
Processing and hygiene: Manufacturing must follow Codex hygiene codes (CXC 1-1969, CXC 75-2015) and validated technologies to preserve nutrient integrity and prevent contamination. Monitoring and Updates: Future revisions to the Codex Guidelines will be automatically adopted unless otherwise specified by the FDA. The circular will be reviewed every three years to assess its effectiveness.

6. Implementation: The circular becomes effective 15 days after publication in the Official Gazette or a newspaper of general circulation and filing with the Office of the National Administrative Register.

This adoption ensures that RUTF products in the Philippines meet global standards, enhancing their safety for vulnerable children and boosting the competitiveness of locally produced therapeutic foods in the international market.

Consumer News Region
Consumer News Tags
Philippines,RUTF,Codex regulation